g.tec medical engineering, a global leader in brain-computer interface (BCI) technology, is set to host the world’s largest BCI & Neurotechnology Meeting. With over 80,000 attendees expected, the conference will feature 140 lectures from 100 elite MIT, Harvard, and Oxford professors. Scheduled for June 2-5 at the Banff Centre for Arts and Creativity, the event will showcase groundbreaking neurotechnology, AI, and BCI application developments.
Dr. Christoph Guger is a pioneer in neurotechnology and the CEO of g.tec. He has spent over two decades leading innovations in BCI technology. His company’s advancements in stroke rehabilitation and brain-machine interactions transform medicine and communication.
At the heart of the BCI & Neurotechnology Meeting, g.tec will present its latest achievements. These include the recovery system, which uses BCI technology to aid stroke recovery, and the Unicorn BCI, which makes high-performance EEG accessible for developers.
“The potential of BCI to restore mobility and communication for those with disabilities is limitless,” Dr. Guger insists. “At g.tec, we are pushing the boundaries of what’s possible by merging AI with BCIs to create seamless human-computer interactions.”
The BCI & Neurotechnology Meeting will highlight the latest research and applications of BCIs in medicine, AI, and beyond. g.tec’s commitment to real-time brain-machine interactions is evident in two clinical applications: stroke rehabilitation and its work with top research institutions. The event aims to inspire collaboration and innovation by bringing together experts from around the globe to shape the future of neurotechnology.
According to Dr. Guger, one of g.tec’s key innovations, the Unicorn BCI, empowers developers and researchers to explore the potential of EEG technology: “We created Unicorn to make high-performance EEG accessible to a broader audience, enabling a wide range of applications in research and beyond.”
With BCIs advancing rapidly, Dr. Guger envisions a future where neurotechnology and AI converge to create non-invasive brain-machine interfaces that enhance human capabilities. “The future of BCIs is about enabling natural, real-time communication between the brain and computers,” he says. “By integrating AI with BCIs, we can unlock new possibilities in medicine, gaming, and everyday applications.”
The BCI & Neurotechnology Meeting also serves as a platform for g.tec’s ongoing educational initiatives, such as the BCI Spring School and BR41N.IO Hackathons. These events aim to educate the next generation of BCI engineers, researchers, and developers. The long-term goal? To further expand the impact of neurotechnology.
g.tec’s leadership in BCI development is reflected in its active role in shaping the future of neuroscience and neurotechnology. With a focus on clinical applications, AI-driven BCIs, and global collaborations, g.tec continues revolutionizing human-computer interaction.
About g.tec
Founded in 1999 by Dr. Christoph Guger and Dr. Günter Edlinger in Austria, g.tec medical engineering specializes in developing high-performance brain-computer interfaces and neurotechnologies for invasive and non-invasive applications in research and clinical environments. The company offers a range of products, including biosignal amplifiers, EEG electrodes, and stimulation devices, supporting brain monitoring and rehabilitation. Renowned for its dedication to innovation and quality, g.tec continues to make significant contributions to the advancement of neurotechnology in the medical engineering field.
For more information on the BCI & Neurotechnology Meeting and g.tec’s forward-looking work, visit g.tec.
As Trump Remakes America, the Political Class Is Dumbstruck
When I came home with a black eye after a fight as a kid, my father imparted to me one…